Display Settings:

Format

Send to:

Choose Destination
Rheumatology (Oxford). 2013 Nov;52(11):1941-51. doi: 10.1093/rheumatology/ket150. Epub 2013 Apr 28.

Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis.

Author information

  • 1Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester Academic Health Sciences Centre, Stopford Building, Oxford Road, Manchester M13 9PT, UK. kimme.hyrich@manchester.ac.uk.

Abstract

There has been a concerted and important international effort to develop and validate disease activity and outcome instruments specific to JIA in recent years. This review aims to describe the disease assessment indices important to routine clinical care and integral to the design of outcome studies and clinical trials in JIA. In view of the increasing number of JIA clinical studies and clinical trials, together with a number of national and international paediatric biologic registers, it is important that knowledge of these new outcome measures is widespread, such that results can be placed in a meaningful context.

KEYWORDS:

JADAS; disease activity; epidemiology; juvenile idiopathic arthritis; outcome measures; paediatric/juvenile rheumatology; standards of care

PMID:
23630368
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk